One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

Detalles Bibliográficos
Autores principales: van der Veldt, A.A.M., Oosting, S.F., Fehrmann, R.S.N., GeurtsvanKessel, C.H., van Binnendijk, R.S., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., Hartog, G. den, Jalving, M., Westphal, T.T., Bhattacharya, A., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829609/
https://www.ncbi.nlm.nih.gov/pubmed/36764094
http://dx.doi.org/10.1016/j.esmoop.2023.100785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829609/
https://www.ncbi.nlm.nih.gov/pubmed/36764094
http://dx.doi.org/10.1016/j.esmoop.2023.100785

Ejemplares similares